Complement regulators C1 inhibitor and CD59 do not significantly inhibit complement activation in Alzheimer disease

Brain Research

Volumn 833, Issue 2, 1999, Pages 297-301

  Yasojima, Koji ^a   McGeer, Edith G ^a   McGeer, Patrick L ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Heart; Inflammation; Kidney; Liver; Myocardial infarction; Neuron; Polymerase chain reaction; Spleen

Indexed keywords

CD59 ANTIGEN; COMPLEMENT COMPONENT C1R; COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT COMPONENT C5; COMPLEMENT COMPONENT C6; COMPLEMENT COMPONENT C7; COMPLEMENT COMPONENT C8; COMPLEMENT COMPONENT C9; MESSENGER RNA;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT INHIBITION; CONTROLLED STUDY; ENTORHINAL CORTEX; GENE EXPRESSION REGULATION; HEART INFARCTION; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANTIGENS, CD59; BLOTTING, WESTERN; BRAIN CHEMISTRY; COMPLEMENT C1; COMPLEMENT C1 INACTIVATOR PROTEINS; COMPLEMENT C1 INHIBITOR PROTEIN; DNA PRIMERS; ENTORHINAL CORTEX; GENE EXPRESSION; HIPPOCAMPUS; HUMANS; KIDNEY; LIVER; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIUM; NEURONS; POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0033519893     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01514-0     Document Type: Article

References (26)

1. Afagh A., Cummings B.J., Cribbs D.H., Cotman C.W., Tenner A.J. Localization and cell association of C1q in Alzheimer's disease brain. Exp. Neurol. 138:1996;22-32.
2. Akatsu H., Yamada T., Okada N., Yamamoto T., Yamashina M., Okada H. Unique expression of HRF20 (CD59) in human nervous tissue. Microbiol. Immunol. 41:1997;321-329.
3. Brachova L., Lue L.-F., Schultz J., Rashidy T.E., Rogers J. Association cortex, cerebellum and serum concentration of C1q and factor B in Alzheimer's disease. Mol. Brain Res. 18:1993;329-334.
4. Eikelenboom P., Hack C.E., Rozemuller J.M., Stam F.C. Complement activation in amyloid plaques in Alzheimer's dementia. Virchows Arch. Cell. Pathol. 56:1989;259-262.
5. Eikelenboom P., Stam F.C. Immunoglobulins and complement factors in senile plaques. An immunoperoxidase study. Acta Neuropathol. 57:1982;239-242.
6. Holm S. A simple sequentially repetitive multiple test procedure. Scand. J. Statist. 6:1979;65-70.
7. Ishii T., Haga S. Immuno-electron-microscopic localization of complements in amyloid fibrils of senile plaques. Acta Neuropathol. (Berlin). 63:1984;296-300.
8. Johnson S.A., Lampert-Etchells M., Pasinetti G.M., Rozovsky I., Finch C.E. Complement mRNA in the mammalian brain: responses to Alzheimer's disease and experimental brain lesioning. Neurobiol. Aging. 13:1992;641-648.
9. McGeer E.G., McGeer P.L. The future use of complement inhibitors for the treatment of neurological diseases. Drugs. 55:1998;739-746.
10. McGeer P.L., Akiyama H., Itagaki S., McGeer E.G. Immune system response in Alzheimer's disease. Can. J. Neurol. Sci. 16:1989;516-527.
11. McGeer P.L., McGeer E.G. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res. Rev. 21:1995;195-218.
12. McGeer P.L., Walker D.G., Akiyama H., Kawamata T., Guan A.L., Parker C.J. Detection of the membrane inhibitor of reactive lysis (CD59) in diseased neurons of Alzheimer brain. Brain Res. 544:1991;315-319.
13. Patston P.A., Gettins P., Beechem J., Schapira M. Mechanism of serpin action: evidence that C1 inhibitor functions as a suicide substrate. Biochemistry. 30:1991;8876-8882.
14. Rogers J., Cooper N.R., Webster S., Schultz J., McGeer P.L., Styren S., Civin W.H., Brachova L., Bradt B., Ward P., Lieberburg I. Complement activation by β-amyloid in Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 89:1992;10016-10020.
15. Rollins S.A., Zhao J.I., Ninomiya H., Sims P.J. Inhibition of homologous complement by CD59 is mediated by a species selective recognition conferred through binding to C8 with C5b-8 or C9 within C5b-9. J. Immunol. 146:1991;2345-2351.
16. Shen Y., Li R., McGeer E.G., McGeer P.L. Neuronal expression of mRNAs for complement proteins of the classical pathway in Alzheimer brain. Brain Res. 769:1997;391-395.
17. Singhrao S.K., Neal J.W., Gasque P., Morgan B.P., Newman G.R. Role of complement in the aetiology of Pick's disease. J. Neuropathol. Exp. Neurol. 55:1996;578-593.
18. Terai K., Walker D.G., McGeer E.G., McGeer P.L. Neurons express proteins of the classical complement pathway in Alzheimer disease. Brain Res. 769:1997;385-390.
19. Veerhuis R., Janssen I., Hoozemans J.J.M., Degroot C.J.A., Hack C.E. C1-inhibitor expression in Alzheimer's disease. Acta Neuropathol. 96:1998;287-296.
20. Walker D.G., McGeer P.L. Complement gene expression in human brain: comparison between normal and Alzheimer disease cases. Mol. Brain Res. 14:1992;109-116.
21. Walker D.G., Yasuhara O., Patston P.A., McGeer E.G., McGeer P.L. Complement C1 inhibitor is produced by brain tissue and is cleaved in Alzheimer disease. Brain Res. 675:1995;75-82.
22. Webster S., Lue L.-F., Brachova L., Tenner A.J., McGeer P.L., Terai K., Walker D.G., Bradt B., Cooper N.R., Rogers J. Molecular and cellular characterization of the membrane attack complex, C5b-9, in Alzheimer's disease. Neurobiol. Aging. 18:1997;415-421.
23. Yasojima K., Kilgore K.S., Washington R.A., Lucchesi B.R., mcGeer P.L. Complement gene expression by rabbit heart: upregulation by ischemia and reperfusion. Circ. Res. 82:1998;1224-1230.
24. Yasojima K., Schwab C., McGeer E.G., McGeer P.L. Human heart generates complement proteins that are upregulated and activated after myocardial infarction. Circ. Res. 83:1998;860-869.
25. Yasojima K., Schwab C., McGeer E.G., McGeer P.L. Upregulated production and activation of the complement system in Alzheimer disease brain. Am. J. Pathol. 154:1999;927-936.
26. Yasuhara O., Walker D.G., McGeer P.L. Hageman factor and its binding sites are present in senile plaques of Alzheimer's disease. Brain Res. 654:1994;234-240.